[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PMVP":3,"homepage-market-summary":31,"stock-news-PMVP":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PMVP","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"PMV Pharmaceuticals, Inc","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.","54","Princeton, NJ",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},1.5,1.59,1.6,1.48,1.61,-0.11,-6.83,607436.265504,3421,1.528,1.91,1.02,508992.0144771514,53.9,1515,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},9,[176,182,188,194,199,205,211,216,221],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"A Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxNdDJ0Y3puT0xvWF9SZW5rWW8xd2NSNWY2cWozODN3MGx2UVQ2dnk0ZTBQalRwWVlYTE9FSUxNS2FQTzZNSEhsV0F1dm5pNVZkTjFCLWJ5Q2dFNWtJanRNWE5jZEk0dlBsdnkxME5aVGNSYmJqNjl4amVkVjJjdUd4Z3J5ekRPUUpxOFBlYmpPU3FCNEtYTURYSmlZWEI5NFU3d0IybDFlU1VEZWsxOXRKaTBR?oc=5","Mon, 05 Oct 2026 12:00:00 GMT","A Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug. Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP - RTTNews","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxOYmVUV0x2cWptUzh3bUV2UUw1bldEYlM5YVB3YnJwekVlRjBnX1hjY3pQYUc3UjF2X09fUVFFNU1LOXNRUFJpa3Fselc2QWhsX3d5TjZQMGVOLUtmXzFHeG9ydWZZY0VUODZDUEQ2LWtEajRqN2lERUtfNFdyZDBCODcwbmpPMTJyUFYyak52Smx2R1hsekVZ?oc=5","Fri, 02 Oct 2026 07:26:00 GMT","Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP RTTNews","RTTNews",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQSmJXejZXQkRlY3h1RUhldzRxMXZZVTRlSEdtVlI1aGZzOWVyRnd5OTNScjFqYTBpT1ZLZGQxdmRoQWRCYTEwX18xRzF5T0JCVFdlY2E4WERrdHNxTU9XaGtoTjFxTGpLb01CVmZzcGVFVkpraHBicjZCSGxwMmhPeV9Vc1ppY0VELTVxRV9RUVJSRmFFMDZBOGw0a1NLbEZkZlFJUXAxX2Jod1hGSi1mbkgwVkE2U2R1WnVyTWR6UnM5cmM?oc=5","Wed, 07 Oct 2026 19:23:54 GMT","PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity Seeking Alpha","Seeking Alpha",{"title":195,"link":196,"pubDate":197,"description":198,"source":181},"Phase 2 single-drug enrollment is complete. PMV Pharma (PMVP) plans an ovarian cancer drug application. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxPaXFHMW1sNEZES1VqWHRtVy1WbXZFYUJMSXQzWXVpeFFDZ3lURlZNNmxONDFYTzQtSzM3LS1ZNG9DUXlrZzJuN2lOdE5BVW9QZDNXc1VVb1lHeXBWLXBBTzBkU0RIeTNDZFhoVTBSS0hpS0ktU1NtYWhBdkppbXdtT0g2elcxeGFPd2NxdWNOM1dpYlItVTZ1cGR0TmpkZ3NzMy10NXlxR3pSaWRMWThvVmN3?oc=5","Mon, 05 Oct 2026 13:00:40 GMT","Phase 2 single-drug enrollment is complete. PMV Pharma (PMVP) plans an ovarian cancer drug application. Stock Titan",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"PMV Pharmaceuticals Director Matthew Joseph Eckler Granted 84,000 Stock Options - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxPLTJKUUFXSXpkRjJWNXdTRndsNS0xMzZHd3ZfMVBmN0JOY3dWTzVpb3F5ODBhU2ZfTm9zQkt0b21iNEhYVW5SN29Oazl2NFRsY3hwQkQ2V2hNUmNEN1Y3dnJYakx3bENhV0c3MnBpdDlBaTVqOEsxd1BLWlBwSEtFMTRWdDdXNVZ2NlpGOUpzZWRiU1AzZmxvR3B0SVpManFYejV1c2N5d2JDelJ4ZXZwTUFrNDVjZUpCal8yVjVNUFpmWEU?oc=5","Mon, 05 Oct 2026 20:20:29 GMT","PMV Pharmaceuticals Director Matthew Joseph Eckler Granted 84,000 Stock Options Kalkine Media","Kalkine Media",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"PMV Pharmaceuticals stock adds Matt Eckler to its board opening the next clinical chapter - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxObnVNbmk2enhma0I0QVA0ZEV0aGhqaWpvNTkxU0ZDSEJjZDJGd1kteWdrWldvNE5KNkRfV21VeS1rZTJMRXZBSS11dnhsZF81MzNObFZhM2lWZ1RCcmx5WFZZSEJFa2xqd3ZtYmQydlJUWHZELU1seWlkN2NJZ3U2WkNZNUlybXlCTWY4ZExDNkF1dV9POVZqSUhVa01XbUxaMkNuUEdtWWNFZnFkR1hKczB1RWdHUzRNR0FQVW52Yi1hNy1aWWh2dU5KYldtUUlQeUNyMl9PRDNzUWwzU3RJT1h3?oc=5","Tue, 06 Oct 2026 22:38:34 GMT","PMV Pharmaceuticals stock adds Matt Eckler to its board opening the next clinical chapter AD HOC NEWS","AD HOC NEWS",{"title":212,"link":213,"pubDate":214,"description":215,"source":187},"Show Me The Money: Kodiak Sciences Shares Deliver More Than 500% Return In Just Over A Year - RTTNews","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPVjlBVndsdURxbm1jaFdBdW5tSFBKM3ZlUE15bFhEa1B3YUJkX2RnMU96aklDclZiaTBrb3JpcktJeGZYa3paNEhzM2hPaWYwSDF1Yi12eExvYmlaVDdNZm9FUGdPNl80RlNOX01QaDgxZ1EzeDN3b1N0WHNkVEJtY1JVTk1EZVBaSThhaFNMalVkVTdjQ2RBemtXNkxiaVItaUtoNkF5MWZNc25iYUZFTW5PVS1VYVlRemZfcmdyNEpKaWl5?oc=5","Fri, 02 Oct 2026 10:23:00 GMT","Show Me The Money: Kodiak Sciences Shares Deliver More Than 500% Return In Just Over A Year RTTNews",{"title":217,"link":218,"pubDate":219,"description":220,"source":181},"Today's SEC Filings - Latest 10-K, 10-Q, 8-K Forms - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiaEFVX3lxTE4wQnhzZURuTWtkUFgwQVQ5WnRXSnZFcVJSMzBOb3lZZ1hzTjBURmFUVG1TWkU5RUUzWXRUMDFDM2pKMThONDBNOVN6cWQ0dG9NSzRaU2hmeHUyUWpjc2JPMlZjVmVNX0NN?oc=5","Mon, 05 Oct 2026 22:22:42 GMT","Today's SEC Filings - Latest 10-K, 10-Q, 8-K Forms Stock Titan",{"title":222,"link":223,"pubDate":224,"description":225,"source":226},"PMV Pharmaceuticals Adds Veteran Investor to Board - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxOTUtBT2ZselQ2V2ZBZ1diVHlaZ1RfanhsZnhxdjV0Zm1sZ0VnbkJZMHdIWlZObjFxcjdPY0dNMnNhbVZGUkIzX25zc2p3S2FqbjVQeHpFN2hzNlhqSG1fZkdYMUNpbzU4THozWWFwejZBNUFDQ1pKSnU4RW5zcDQwYUdMZW1vWk1XeEZZTUJBSDJCak5iRE9ucHN0dWljNGk0Ml9SUA?oc=5","Mon, 05 Oct 2026 13:40:02 GMT","PMV Pharmaceuticals Adds Veteran Investor to Board TipRanks","TipRanks"]